Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs

Source

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.

Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs

Latest:

US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties

White House sends letter urging news outlets to ‘ramp up scrutiny’ of Biden impeachment inquiry

Redacted

President Biden’s White House has told America’s news organizations — including CNN, the New York Times and Fox News — to “ramp up their scrutiny” of House Republicans “for opening an impeachment inquiry based on lies.”

White House sends letter urging news outlets to ‘ramp up scrutiny’ of Biden impeachment inquiry

The specter of socialism haunts US Congress

*Trigger Warning*: this talks about socialism, which seems to trigger some of those who follow my blog. If you don’t like something, that I post, either scroll on by or unfollow me!

A specter is haunting Congress: the specter of socialism.

Last week, as the US Congress discussed approving billions more dollars in weapons for the war against Russia and began negotiating cuts to social programs in advance of the debt ceiling expiration, the House spent three days discussing and adopting a resolution denouncing socialism and pledging to reverse all the social gains made by the working class on a global scale in the century since the Russian Revolution of 1917.

Before the resolution was brought to a vote Thursday, the Republican-controlled House Rules Committee rejected a proposed amendment introduced by Democrats that would have clarified “that opposition to the implementation of socialist policies in the US does not include federal programs like Medicare and Social Security,” according to the Hill.

The specter of socialism haunts US Congress